Characterization and preclinical evaluation of a protease activated receptor 2 (PAR2) monoclonal antibody as a preventive therapy for migraine
Caroline M. Kopruszinski, Peter Thornton, Joanne Arnold, Philip Newton, David Lowne, Edita Navratilova, Juliana Swiokla, David W. Dodick, Claire Dobson, Ian Gurrell, Iain Patrick Chessell, Frank Porreca
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Characterization and preclinical evaluation of a protease activated receptor 2 (PAR2) monoclonal antibody as a preventive therapy for migraine'. Together they form a unique fingerprint.